The mission of SNBL Group is to free patients from suffering by supporting drug development and improving medical technology.
The nonclinical research division of SNBL is Japan’s largest and oldest nonclinical CRO.
For over 65 years, we have balanced speed with superior quality, carrying out studies efficiently, accurately and in a timely manner, consistently exceeding our customers’ expectations; because this is not just a job, it’s our passion.
At SNBL, we embrace the challenges of innovation, growth and development in order to provide a meaningful contribution to the well-being of all people.
Contact us at info@snbl.co.jp today to learn more about our capabilities.
Company Details
- Employees
- 249
- Founded
- -
- Address
- 2438 Miyanoura, Kagoshima,kagoshima 891-1394,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- snbljapan.com
- Keywords
- Preclinical, DART, Efficacy Models, General Toxicity, Specific Toxicity, Toxicology, CRO, Safety Pharmacology, Genotoxicity, Bioanalysis, Ophthalmology, Translational Research, Out-Licensing Business.
- HQ
- Kagoshima, Kagoshima
Snbl Questions
Snbl's website is snbljapan.com
Snbl's LinkedIn profile is https://www.linkedin.com/company/snbl-japan
Snbl has
249 employees.
View email and phone details for 249
employees at Snbl.
Snbl's industry is
Biotechnology Research
Snbl's top competitors are
Fred Hutch,
Cmic Group,
Gemseki,
Altasciences,
（株）新日本科学,
Ppd-Snbl,
Sbi Investment,
Plug And Play Tech Center,
Sbi Holdings Usa, Inc.,
Ppd.
Snbl's categories are Biotechnology Research
Snbl's founding year is 1957
